SCHEMBL3978765

SCHEMBL3978765

CCCOc1ccccc1-c1ccoc1C(=O)OC(=O)c1ccc(O)c(C#N)c1C(=O)NN

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGCG Q16739 1/20 0.32
GAA P10253 1/20 0.32
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
ADRB3 P13945 1/20 0.32
HPGD P15428 2/20 0.32
TSHR P16473 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
HIF1A Q16665 1/20 0.32
MAPT P10636 1/20 0.32
HSD17B10 Q99714 1/20 0.32
LCLAT1 Q6UWP7 1/20 0.31
CNR2 P34972 1/20 0.31
AR P10275 1/20 0.31
POLB P06746 1/20 0.31
LMNA P02545 1/20 0.31
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.30
STK17B O94768 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3974737 0.90 ALDH1A1 (0.35) MEN1KMT2ACNR2ALDH1A1
SCHEMBL3975349 0.88 MCL1 (0.40) GAAMAPTALDH1A1KDM4E
SCHEMBL3976647 0.87 IDO1 (0.34) LMNA
SCHEMBL3976979 0.86 IKBKB (0.34) GAAALDH1A1
SCHEMBL3977209 0.86 HSD17B10 (0.34) HPGDTSHRMEN1KMT2AMAPT
SCHEMBL3977768 0.85 ADCYAP1R1 (0.32)
SCHEMBL3978625 0.85 FAAH (0.36) CNR2
SCHEMBL3978191 0.84 ALDH1A1 (0.35) GAAHPGDTSHRMEN1KMT2A
SCHEMBL3974765 0.84 ALDH1A1 (0.36) GAAHPGDTSHRMEN1KMT2A
SCHEMBL3976427 0.81 USP2 (0.38) GAAADRB2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 UGCG 1425/4885GAA 1023/4885ADRB2 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.